Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: DOC stock price vs DPZ: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DPZ's multiple
Needs DPZ P/E.
Implied fair value · at DOC's multiple
Needs DOC P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Healthpeak Properties, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Domino’s Pizza, Inc. · implied price per share
Bear
$65.44
Base
$101.10
Bull
$147.54
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
WELLTOWER INC.
DOC vs WELL
Ventas, Inc.
DOC vs VTR
ALEXANDRIA REAL ESTATE EQUITIES, INC.
DOC vs ARE
SL GREEN REALTY CORP
DOC vs SLG
MCDONALDS CORP
DOC vs MCD
YUM BRANDS INC
DOC vs YUM
STARBUCKS CORP
DOC vs SBUX
Wendy's Co
DOC vs WEN
CHIPOTLE MEXICAN GRILL INC
DOC vs CMG
DARDEN RESTAURANTS INC
DOC vs DRI
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe DOC can materially improve profitability and reduce leverage enough to justify a far higher multiple, then maintain or add exposure; otherwise, the data argues for avoiding DOC because it is priced far above DPZ on every valuation metric while fundamentals and balance-sheet quality are weaker.
DOC trades at a steep premium to DPZ on both earnings and sales metrics, yet the provided implied price suggests severe downside. The gap appears driven by DOC's much higher P/E, EV/EBITDA, and EV/Revenue multiples despite lower profitability and weaker balance-sheet metrics.
Supporting Metrics
